Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.11, 2001-11, pp. : 1069-1077

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic evaluations alongside phase III trials?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 424, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?

By Hill S.

PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. : 761-767

Adis International

Access to resources Recommend Favorite

Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations: Does the Choice of Hospitals Make a Difference?

By Goeree R.

PharmacoEconomics, Vol. 15, Iss. 6, 1999-06 ,pp. : 561-572

Adis International

Access to resources Recommend Favorite

Analysis Sans Frontières: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?

By Sculpher Mark J. Drummond Michael F.

PharmacoEconomics, Vol. 24, Iss. 11, 2006-01 ,pp. : 1087-1099

Adis International

Access to resources Recommend Favorite

Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis

By Fleurence Rachael L.

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 295-306

Adis International

Access to resources Recommend Favorite